Detalhe da pesquisa
1.
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(5): 609-619, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845034
2.
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer.
Gynecol Oncol
; 163(2): 254-261, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474927
3.
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial.
Lancet Oncol
; 20(3): 383-393, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745090
4.
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 375(19): 1823-1833, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718847
5.
Pembrolizumab for the treatment of non-small-cell lung cancer.
N Engl J Med
; 372(21): 2018-28, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891174
6.
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Lancet Oncol
; 18(12): 1600-1609, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129441
7.
Adverse Event Profile by Folate Receptor Status for Vintafolide and Pegylated Liposomal Doxorubicin in Combination, Versus Pegylated Liposomal Doxorubicin Alone, in Platinum-Resistant Ovarian Cancer: Exploratory Analysis of the Phase II PRECEDENT Trial.
Int J Gynecol Cancer
; 26(9): 1580-1585, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27654255
8.
Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer.
iScience
; 27(5): 109801, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726365
9.
Coordinate control of axon defasciculation and myelination by laminin-2 and -8.
J Cell Biol
; 168(4): 655-66, 2005 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15699217
10.
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Clin Cancer Res
; 26(6): 1220-1228, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796521
11.
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.
J Clin Oncol
; 35(36): 4035-4041, 2017 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29095678
12.
CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells.
Appl Immunohistochem Mol Morphol
; 10(1): 34-9, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11893033
13.
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.
Autophagy
; 10(8): 1380-90, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24991834
14.
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.
Autophagy
; 10(8): 1391-402, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24991838
15.
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.
Autophagy
; 10(8): 1369-79, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24991839
16.
Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.
J Biol Chem
; 280(12): 11790-7, 2005 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15659388
17.
Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection.
J Immunol
; 169(6): 3046-52, 2002 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12218120
18.
Hyaluronate-based extracellular matrix: keeping glia in their place.
Glia
; 38(2): 93-102, 2002 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11948803